Inventor
STOGNIEW MARTIN
US49 patents
⚠️ This page may combine multiple inventors who share the name “STOGNIEW MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIMMUNE ONCOLOGY INC
14 patentsUS6489312B1Dec 3, 2002
Pharmaceutical formulations comprising aminoalkyl phosphorothioates
MEDIMMUNE ONCOLOGY INC49 citations95
US6258821B1Jul 10, 2001
Compositions comprising trimetrexate and methods of their synthesis and use
MEDIMMUNE ONCOLOGY INC43 citations95
US6573253B2Jun 3, 2003
Methods for the administration of amifostine and related compounds
MEDIMMUNE ONCOLOGY INC20 citations92
US6218377B1Apr 17, 2001
Methods for the administration of amifostine and related compounds
MEDIMMUNE ONCOLOGY INC22 citations92
US6407278B2Jun 18, 2002
Stable amorphous amifostine compositions and methods for the preparation and use of the same
MEDIMMUNE ONCOLOGY INC22 citations91
US6384259B1May 7, 2002
Stable amorphous amifostine compositions and dosage form
MEDIMMUNE ONCOLOGY INC25 citations91
US6586476B1Jul 1, 2003
Methods for the treatment of nephro-disorders using aminothiol compounds
MEDIMMUNE ONCOLOGY INC13 citations90
US6239119B1May 29, 2001
Topical administration of amifostine and related compounds
MEDIMMUNE ONCOLOGY INC35 citations90
US6127351AOct 3, 2000
Method for the administration of amifostine and related compounds
MEDIMMUNE ONCOLOGY INC15 citations82
US6841545B2Jan 11, 2005
Stable amorphous amifostine compositions and methods for the preparation of same
MEDIMMUNE ONCOLOGY INC6 citations72
US6753323B2Jun 22, 2004
Topical administration of amifostine and related compounds
MEDIMMUNE ONCOLOGY INC6 citations71
US6258952B1Jul 10, 2001
Thermally stable trimetrexates and processes for producing the same
MEDIMMUNE ONCOLOGY INC6 citations70
US6576635B2Jun 10, 2003
Compositions comprising trimetrexate
MEDIMMUNE ONCOLOGY INC1 citations61
US7105575B2Sep 12, 2006
Methods for the treatment of neuro- disorders using aminothiol compounds
MEDIMMUNE ONCOLOGY INC1 citations60
ONCOCEUTICS INC
13 patentsUS9688679B2Jun 27, 2017
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC7 citations83
US9376437B2Jun 28, 2016
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC11 citations83
US9265765B2Feb 23, 2016
7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC10 citations83
US10172862B2Jan 8, 2019
Imipridones for gliomas
ONCOCEUTICS INC5 citations82
US10456402B2Oct 29, 2019
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC1 citations72
US10266533B2Apr 23, 2019
7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy
ONCOCEUTICS INC1 citations72
US10369154B2Aug 6, 2019
Imipridones for gliomas
ONCOCEUTICS INC1 citations71
US10953014B2Mar 23, 2021
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC0 citations62
US9845324B2Dec 19, 2017
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy
ONCOCEUTICS INC1 citations61
US12102639B2Oct 1, 2024
Imipridones for gliomas
ONCOCEUTICS INC0 citations60
US11116771B2Sep 14, 2021
G protein-coupled receptor (GPCR) modulation by imipridones
ONCOCEUTICS INC0 citations60
US10946022B2Mar 16, 2021
Imipridones for gliomas
ONCOCEUTICS INC0 citations60
US10045992B2Aug 14, 2018
7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy
ONCOCEUTICS INC0 citations51
TRANSCEND THERAPEUTICS INC
7 patentsUS11707446B2Jul 25, 2023
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC4 citations80
US12343326B2Jul 1, 2025
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC0 citations59
US12233046B2Feb 25, 2025
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC0 citations59
US12295937B2May 13, 2025
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC0 citations57
US12059402B2Aug 13, 2024
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC0 citations57
US11969407B2Apr 30, 2024
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TRANSCEND THERAPEUTICS INC0 citations57
US12297220B2May 13, 2025
Phenethylamines and cathinones precursors
TRANSCEND THERAPEUTICS INC0 citations49
VICURON PHARM INC
5 patentsUS7198796B2Apr 3, 2007
Antifungal parenteral products
VICURON PHARM INC21 citations92
US7119061B2Oct 10, 2006
Dalbavancin compositions for treatment of bacterial infections
VICURON PHARM INC11 citations84
US7115564B2Oct 3, 2006
Stable pharmaceutical compositions of dalbavancin and methods of administration
VICURON PHARM INC5 citations71
US6900175B2May 31, 2005
Methods of administering dalbavancin for treatment of bacterial infections
VICURON PHARM INC9 citations71
US6991800B2Jan 31, 2006
Antifungal parenteral products
VICURON PHARM INC4 citations63
US BIOSCIENCE
3 patentsUS5994409ANov 30, 1999
Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US BIOSCIENCE53 citations94
US6017922AJan 25, 2000
Thermally stable trimetrexates and processes for producing the same
US BIOSCIENCE20 citations89
US6051563AApr 18, 2000
Methods for the administration of amifostine and related compounds
US BIOSCIENCE15 citations82